Literature DB >> 29614378

The role of avoidance behavior in the treatment of adolescents with irritable bowel syndrome: A mediation analysis.

Marianne Bonnert1, Ola Olén2, Johan Bjureberg3, Maria Lalouni4, Erik Hedman-Lagerlöf5, Eva Serlachius6, Brjánn Ljótsson7.   

Abstract

Irritable bowel syndrome (IBS) is common in adolescents with a pronounced negative impact on quality of life. A pattern of avoidance behavior is commonly seen in the IBS population, which is associated with more gastrointestinal (GI) symptoms. Exposure-based cognitive behavior therapy (CBT) targets the avoidance behavior to reduce symptoms, but it is unknown whether reduced avoidance is a mediator of symptom improvement in adolescent IBS. Stress has been suggested to play a key role in worsening GI symptoms and is also a potential mediator of the treatment effect in IBS. This study was based on data from a randomized controlled trial (N = 101) that evaluated exposure-based internet-delivered CBT (Internet-CBT) compared with a wait-list for adolescents with IBS. We investigated whether avoidance behavior and perceived stress mediated the improvement in global GI symptoms due to treatment. We found that a change in avoidance behavior, but not perceived stress, mediated the effect of exposure-based Internet-CBT on GI symptoms. The decrease in avoidance behavior explained a large portion (67%) of the total treatment effect. Moreover, a unidirectional relationship over time was observed between avoidance behavior and GI symptoms. Our conclusion is that exposure-based CBT in adolescent IBS reduces avoidance and, consequently, reduces GI symptoms.
Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Adolescents; Avoidance behavior; Cognitive behavior therapy; Exposure-based treatment; Irritable bowel syndrome; Mediation analysis; NCT02306369

Mesh:

Year:  2018        PMID: 29614378     DOI: 10.1016/j.brat.2018.03.006

Source DB:  PubMed          Journal:  Behav Res Ther        ISSN: 0005-7967


  8 in total

1.  The Emerging Role of Brain-Gut Therapies for Irritable Bowel Syndrome.

Authors:  Megan E Riehl
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-07

2.  Cognitive-behavioural therapy for children with irritable bowel syndrome.

Authors:  Ashley Buffone; Ran D Goldman
Journal:  Can Fam Physician       Date:  2021-12       Impact factor: 3.275

3. 

Authors:  Ashley Buffone; Ran D Goldman
Journal:  Can Fam Physician       Date:  2021-12       Impact factor: 3.275

4.  Mediation of outcomes for cognitive behavioral therapy targeted to parents of children with Functional Abdominal Pain Disorders.

Authors:  Miranda A L van Tilburg; Rona L Levy; Susan Stoner; Joan M Romano; Tasha B Murphy; Bisher Abdullah; Lloyd Mancl; Andrew D Feld
Journal:  J Psychosom Res       Date:  2021-09-15       Impact factor: 3.006

5.  Change in avoidance and negative grief-related cognitions mediates treatment outcome in older adults with prolonged grief disorder.

Authors:  Franziska Lechner-Meichsner; Christine Mauro; Natalia A Skritskaya; M Katherine Shear
Journal:  Psychother Res       Date:  2021-04-05

6.  Validity and reliability of the Japanese versions of cognitive and behavioral scales for irritable bowel syndrome.

Authors:  Nagisa Sugaya; Yoshitoshi Tomita; Misako Funaba; Hiroshi Iida; Kentaro Shirotsuki; Fumiyuki Chin Gardner; Toshinari Odawara; Tetsuya Ando; Masahiko Inamori
Journal:  Biopsychosoc Med       Date:  2022-07-23

7.  Parental responses and catastrophizing in online cognitive behavioral therapy for pediatric functional abdominal pain: A mediation analysis of a randomized controlled trial.

Authors:  Maria Lalouni; Aleksandra Bujacz; Marianne Bonnert; Karin B Jensen; Anna Rosengren; Erik Hedman-Lagerlöf; Eva Serlachius; Ola Olén; Brjánn Ljótsson
Journal:  Front Pain Res (Lausanne)       Date:  2022-10-03

8.  Validation of child-adapted short scales for measuring gastrointestinal-specific avoidance and anxiety.

Authors:  Maria Lalouni; Ola Olén; Johan Bjureberg; Marianne Bonnert; Trudie Chalder; Erik Hedman-Lagerlöf; Silje Endresen Reme; Eva Serlachius; Brjánn Ljótsson
Journal:  Acta Paediatr       Date:  2022-05-27       Impact factor: 4.056

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.